Russia Group Backs Facility For Biomedical, Preclinical Research
This article was originally published in PharmAsia News
Executive Summary
Russia’s Skolkovo Foundation plans a $50 million investment in a center for conducting biomedical and preclinical research of drugs that would meet international standards.